The VET PFAS Act amends Title 38 to require the Department of Veterans Affairs to furnish hospital care and medical services to veterans who served at military installations where perfluorooctanoic acid (PFOA) or other PFAS contaminated drinking water or otherwise exposed personnel. The bill creates a statutory presumption of service connection for a defined list of conditions linked to PFOA and for any additional PFAS-related conditions the VA identifies in consultation with ATSDR based on the NDAA 2018 study.
The Act also extends a limited eligibility pathway to family members (including individuals exposed in utero) who resided at covered installations, conditions VA’s family care obligations on appropriations and exhaustion of third-party remedies, and requires annual reporting to Congressional veterans committees during a three-year window tied to the ATSDR study submission. For compliance officers and policy teams, the bill replaces case-by-case causation fights with a mix of bright-line presumptions and delegated scientific determinations — and shifts significant fiscal and administrative burdens onto VA and other payors.
At a Glance
What It Does
The bill inserts a new subsection into 38 U.S.C. §1710 to make veterans who served at PFAS-contaminated installations eligible for VA hospital care for specified conditions, creates 38 U.S.C. §1116C establishing presumptive service connection for those conditions, and adds 38 U.S.C. §1787A to let certain family members obtain VA care. It directs VA to rely on the NDAA 2018/ATSDR study to identify additional PFAS-linked conditions.
Who It Affects
Veterans who served at installations with documented PFOA/PFAS exposure, family members who lived at those locations (including prenatal exposure), VA administrators and clinicians, private health plans and other third-party payors who must be exhausted before VA reimburses, and Congressional appropriators.
Why It Matters
The bill substitutes statutory presumptions for individualized causation reviews for a set of PFAS-linked conditions, accelerating access to VA care while creating new budgetary and administrative demands on VA and complicating subrogation and coordination with private payors.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The VET PFAS Act makes three interlocking changes to Title 38. First, it amends VA’s hospital care eligibility rules to allow veterans who served at military installations where people were exposed to PFOA or other PFAS to receive hospital care and medical services for certain conditions even when medical evidence tying the condition to service is limited.
For PFOA the bill lists six conditions specifically; for other PFAS it delegates identification of associated conditions to VA in consultation with ATSDR, using the NDAA 2018 study as the basis for a ‘‘positive association’’ determination.
Second, the bill creates a narrow family-member eligibility pathway. Family members who lived at covered installations — and those exposed in utero while a parent resided there — may receive VA hospital care for the same set of PFAS-linked conditions, but VA may only provide that care if Congress appropriates funds and only after the family member or provider has exhausted reasonable claims and remedies against third parties, including health-plan claims.
VA can also deny coverage where guidelines show the condition resulted from a cause other than residency at the covered location.Third, the Act establishes a statutory presumption of service connection for veterans who served at contaminated installations: if a listed disease manifests, VA must treat it as service-connected for compensation purposes, subject to usual statutory limitations. The bill also clarifies that specified reserve service at covered sites counts as active duty for these purposes and defines ‘‘covered military installation’’ to include installations with contaminated drinking wells.Finally, the bill adds a short-term transparency obligation: VA must deliver annual reports to the Congressional veterans committees for three years after the ATSDR study submission, detailing numbers of veterans and family members receiving care, conditions treated, denials and reasons, and pending applications.
Those reports are designed to track program uptake and to inform future policymaking and budgeting.
The Five Things You Need to Know
The Act becomes effective for VA provision of care and family-member eligibility 90 days after enactment.
For PFOA exposure the statute lists six presumptive conditions: diagnosed high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension.
VA must treat certain reserve-component service at covered installations as active duty for eligibility and presumption purposes.
Family-member care (including for in utero exposure) is conditioned on appropriations, can be denied if another cause is established, and reimbursement by VA requires exhaustion of claims against third-party payors.
VA must submit annual reports to the House and Senate Veterans’ Affairs Committees for three years tied to the ATSDR/NDAA 2018 study, reporting counts of care provided, conditions treated, denials and pending applications.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Eligibility for VA hospital care tied to PFAS exposure
The bill adds subparagraph (J) to §1710(e)(1) to make veterans who served at installations where individuals were exposed to PFOA or other PFAS eligible for hospital care and medical services even when direct medical evidence linking the condition to service is insufficient. The provision distinguishes between explicit PFOA-linked conditions (a finite list) and other PFAS where VA must use the NDAA 2018/ATSDR study to determine ‘‘positive associations.’” Practically, this turns a subset of PFAS claims into administrable eligibility rules rather than purely individualized causation disputes.
Scoped disease list, delegation to ATSDR, and definition of covered installation
Clause (ii) enumerates six conditions tied to PFOA and delegates identification of additional PFAS-associated diseases to the Secretary, in consultation with ATSDR and based on the NDAA 2018 study. Clause (iii) instructs VA to treat specified reserve-component service at covered installations as active duty. Clause (iv) defines ‘‘covered military installation’’ broadly to include sites with PFAS-contaminated drinking wells — a functional definition likely to capture many bases with known water contamination.
Family-member eligibility and limits
The bill creates a new section granting family members who resided at covered installations (and individuals exposed in utero) access to VA hospital care for the same PFAS-linked conditions. That eligibility is explicitly qualified: VA can furnish care only to the extent provided in advance by appropriations, may exclude care when guidelines attribute the condition to another cause, and can provide reimbursement only after exhaustion of third-party claims (including health-plan claims).
Three-year reporting obligation tied to ATSDR study
VA must submit annual reports to the House and Senate Veterans’ Affairs Committees during the three-year period beginning in the year the NDAA 2018/ATSDR study is submitted. Each report must enumerate veterans and family members served, list illnesses and disabilities treated, tally denials and reasons, and count pending eligibility decisions — information intended to measure program uptake and denial drivers during the initial implementation window.
New presumptive-service-connection statute
The bill inserts §1116C to create a statutory presumption of service connection for veterans who served at PFAS-contaminated installations when a listed disease manifests. The presumption mirrors the eligibility changes but applies in the compensation context, so qualifying veterans can receive service-connected benefits without proof of causation during service. The section again covers PFOA-specific diseases and authorizes VA to list additional PFAS-linked conditions in consultation with ATSDR.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans who served at PFAS-contaminated installations — they gain faster access to VA hospital care and a statutory presumption for compensation for defined conditions, reducing evidentiary hurdles.
- Family members and individuals exposed in utero who lived on affected installations — they become eligible for VA-provided hospital care for the same PFAS-linked conditions, a change that recognizes residential exposure pathways.
- Reserve-component members with qualifying service at contaminated sites — the bill treats that specified reserve service as active duty for eligibility and presumption purposes, expanding coverage to many reservists previously excluded.
Who Bears the Cost
- Department of Veterans Affairs — VA will shoulder new clinical workload, claims processing, and reporting obligations, and will require appropriations to fund family-member care; administrative scaling and specialty care demand will rise.
- Federal appropriators/the Treasury — family-member care is explicitly limited to amounts provided in advance by Congress, so costs shift to the budget process and could be substantial depending on uptake.
- Private health insurers and other third-party payors — the statute requires exhaustion of claims and remedies against third parties before VA reimburses family-member care, increasing subrogation activity and potential cash-flow impacts for providers and insurers.
Key Issues
The Core Tension
The central dilemma is balancing speedy, low-evidence access to care for potentially harmed veterans and families against fiscal discipline and scientific certainty: presumptions and delegated determinations accelerate benefits but shift financial risk to VA and appropriators and rest on evolving science that may be incomplete or contested.
The bill simplifies access to care by creating statutory presumptions and delegating PFAS condition identification to VA in consultation with ATSDR, but that approach raises implementation and fiscal questions. Relying on the NDAA 2018/ATSDR study to identify additional PFAS-linked conditions creates a timing dependency: VA cannot expand coverage for other PFAS until the scientific review yields ‘‘positive associations,’’ yet eligibility for the six PFOA conditions takes effect quickly.
That sequencing may produce pressure to interpret the study expansively or to face calls to add conditions administratively.
Family-member coverage is limited by appropriations and the requirement that claimants exhaust third-party remedies first. Those constraints reduce immediate federal outlays but could delay care for exposed family members and shift costs to private insurers and providers while increasing subrogation and litigation.
The broad language defining ‘‘covered military installation’’ (including contaminated wells) is practical but imprecise; disputes over when an installation qualifies will create administrative backlog and potential litigation. Finally, treating reserve service as active for these claims addresses an equity concern but introduces retroactivity and record-evidence issues — verifying past residence and exposure for temporally limited reserve activations will be administratively heavy.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.